Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Blockchain and Medicine: Aimedis Launches First Medicine NFT

CryptocurrencyNov 01, 2021 11:02AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
Blockchain and Medicine: Aimedis Launches First Medicine NFT

There is an enormous amount of medical data out there, but the healthcare industry remains flawed, and its data is difficult to use for research purposes due to its overall poor quality and lack of transparency. Obtaining accurate, reliable data can improve medicine and therefore people’s everyday lives on a global basis. Blockchain technology could be the best solution for these data-related issues within the industry.

Aimedis, founded in 2020, is a blockchain-based platform that offers various affordable and effective health services, including teleconsulting, appointment management, getting prescriptions, medical records, connecting to tracking devices, and more.

The platform itself is active in almost every continent, with a large number of patients already onboarded, and a goal of reaching 1 million patients by the end of 2022.

Aimedis is launching the first scientific and medical NFT marketplace in November, starting with a cancer trial.

The founders of Aimedis, Ben J.O. El Idrissi and Michael J. Kaldasch, are doctors who have worked in medicine and pharmaceuticals for over ten years. During an exclusive interview, Kaldasch told DailyCoin about the flaws of the pharmaceutical industry, and how, with the help of blockchain technology, Aimedis seeks to improve research and data quality in the healthcare industry.

The Need to Improve the Traditional Pharmaceutical Industry

The old ways that pharmaceutical trial studies work consumes a lot of time and money. The pharmaceutical industry spends billions of dollars to perform trials, of which around 90% fail. There is a lot of data in the medical industry, with dummy data used in trials too. Nevertheless, sometimes drugs work out well and are verified after successful trials with inaccurate data.

“We've been working in the pharmaceutical industry for quite some time and we know well the insights of it. I was a drug safety officer for some time, and I did some trials for large pharmaceutical companies. I had to deal with problematic data, and I saw the process of how the data is used and generated.

In some instances, there were a lot of paper sheets with hard-to-read or accidentally deleted information. Even when you take a look at electronic documents, you still don't know what has been changed, and whether the data is real and genuine,” Kaldasch explained.

Often, especially in developing countries, people are exploited for their data, and participate in pharmaceutical trials without even knowing as much. Due to this, some people and corporations make good money gathering data, while patients are completely left out.

Blockchain Can Bring High Quality Data to the Medical Industry

With the NFT marketplace, Aimedis is seeking to change the system completely. Hospitals, researchers, health care providers, and doctors will be able to generate NFTs and put anonymized data into them, sign the data, and then sell it to the pharmaceutical industry, researchers, and AI companies. This is important because, even with artificial intelligence, if the data is incorrect and of poor quality, the advanced technology being utilized will be rendered useless.

Kaldasch explained that the platform works in such a way that no one would have any access to patients’ information. Patients would have to actively opt in to their data being used or stored into NFTs. There will also be a dashboard, which will provide information about the trial. Depending on the data required, individuals can choose to participate, though they will not be able to upload data by themselves. Participants will always have to go through healthcare professionals to avoid generating dummy, or false medical data for the sake of earning money. Only medical professionals can upload data (in the form of an NFT) from patients that decide to participate while staying anonymous.

“Another important fact is that we finance the trials that we do while we are selling the NFTs. So this makes us independent from the pharmaceutical industry. Imagine you have a drug that is examined. Normally, the pharmaceutical company that produces the drug finances the trial, which can be problematic,” the Aimedis CEO said.

Aimedis also wants to help the pharmaceutical industry to avoid the issue of false data. That way companies can save a lot of time and money, because every NFT bought has a certain structure, and a certain type of data. They can thus rely on them to buy an NFT, and thereby gain access to valuable data.

When someone asks about the price of medical data from patients with cancer or heart conditions, it’s impossible to give an accurate quote, because for each trial there are separate prices. It all depends on how much effort and how much money was put into the generation of patient groups and the study’s design. With NFTs, it will become possible to provide a price tag, after some time.

“We also have the opportunity to start trials and examinations regarding orphan diseases, where the pharmaceutical company is not so active because there are not many people suffering from such illnesses,” Kaldasch underlined.

Since the pharmaceutical industry must earn money from what they do, producing certain drugs and looking for cures for rare diseases isn’t profitable, due to the low number of people who would buy the drug.

The AIMx Token and the New Project

The AIMx token is part of the NFT marketplace. People who mint or buy the token receive a discount when they use it. This is an intrinsic aspect to motivate the use of the token inside the NFT marketplace system. AIMx has several functionalities: payment, utility, governance, DeFi, and is even a social token.

The social component will come into play next year with a social medical platform where patients can interact with each other, and self-help groups can be created. Healthcare professionals will always ensure that the information produced is valid prior to its use. Governance in Aimedis will be done by token holders, who can decide on the happenings within the social medical channels, as well as the functionalities of the internal system.

On The Flipside

  • For blockchain to be fully effective in the healthcare industry, the technology has to be combined with other systems, and have enough participants in medical trials.
  • Technological transitions will take time to be fully implemented within the industry.

Why You Should Care?

There is global demand for improvements to medical data and transparency in the pharmaceutical industry. Blockchain can be revolutionary in the medical industry, as it can inherently help to provide clarity to medical records, offer tools for medical specialists, and connect research companies with hospitals and patients across the globe.


Join to get the flipside of crypto

Upgrade your inbox and get our DailyCoin editors’ picks 1x a week delivered straight to your inbox.

[contact-form-7] You can always unsubscribe with just 1 click.

Continue reading on DailyCoin

Blockchain and Medicine: Aimedis Launches First Medicine NFT

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Antonio Varese
Antonio Varese Nov 02, 2021 5:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That is a brilliant idea to be honest... the more I think about it, the more it makes sense. Why did I not think about that?
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email